Vyteris announces phase II trial results of transdermal patch for female infertility - Clinical Trials
Links shared publicly online about this topic.
- 951total visits
Vyteris announces phase II trial results of transdermal patch for female infertility - Clinical Trials
Vyteris, Inc., developer of the first FDA-approved active transdermal patch and a leader in alternative drug delivery technology, announced positive results from a phase II clinical trial evaluating the safety and efficacy
View full resource at pharmabiz.com
Tags: Infertility, Drug, Clinical Trial, Women's Health, Safety
Most Recently Shared on August 13, 2010 at 10:48 am By:
Vyteris announces phase II trial results of transdermal patch for female infertility: Vyteris, Inc., developer of ... http://bit.ly/br3w2X
Advertisement
